approval
saveXTANDI (ENZALUTAMIDE) — FDA approval
community read0 votes
Sponsor: ASTELLAS. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalXTANDI (ENZALUTAMIDE) — FDA approvalDec 11, 2025 · 303d ago
- approvalXTANDI (ENZALUTAMIDE) — FDA approvalDec 11, 2025 · 303d ago
- approvalXTANDI (ENZALUTAMIDE) — FDA approvalMar 21, 2025 · 568d ago
- approvalXTANDI (ENZALUTAMIDE) — FDA approvalJan 22, 2025 · 626d ago
- approvalXTANDI (ENZALUTAMIDE) — FDA approvalJan 22, 2025 · 626d ago
- approvalXTANDI (ENZALUTAMIDE) — FDA approvalNov 16, 2023 · 1059d ago
- approvalXTANDI (ENZALUTAMIDE) — FDA approvalNov 16, 2023 · 1059d ago
- approvalXTANDI (ENZALUTAMIDE) — FDA approvalSep 9, 2022 · 1492d ago
same company · ±60 days · 5
- approvalenzalutamide: XTANDI (ENZALUTAMIDE) — FDA approvalMar 21, 2025
- approvalenfortumab vedotin: PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalFeb 27, 2025
- approvalavacincaptad pegol sodium: IZERVAY (AVACINCAPTAD PEGOL SODIUM) — FDA approvalFeb 12, 2025
- approvalenzalutamide: XTANDI (ENZALUTAMIDE) — FDA approvalJan 22, 2025
- approvalenzalutamide: XTANDI (ENZALUTAMIDE) — FDA approvalJan 22, 2025
comments(0)
5-min edit window · permanent after that